Lepor agreed that, "on the basis of this study, intermittent androgen [hormonal] deprivation therapy should no longer be recommended for those men with minimal disease spread."
Findings presented at medical meetings are typically considered preliminary until published in a peer-reviewed journal.
More information
There's more on treatments for prostate cancer at the American Cancer Society.
Copyright © 2012 HealthDay. All rights reserved.
Reader Comments Read all comments (5)